D-xime is a high-quality sterile dry injection containing Cefuroxime Sodium IP equivalent to Cefuroxime Anhydrous 750mg per vial. Manufactured under stringent quality assurance pro...

D-xime is a high-quality sterile dry injection containing Cefuroxime Sodium IP equivalent to Cefuroxime Anhydrous 750mg per vial. Manufactured under stringent quality assurance protocols, this second-generation cephalosporin antibiotic ensures purity, potency, and safety for medical applications. Designed for reconstitution with sterile water or appropriate diluents before intravenous or intramuscular administration, it delivers broad-spectrum activity against both gram-positive and gram-negative bacteria. The sealed vial packaging maintains sterility and extends shelf life, providing healthcare providers with a dependable solution for effective infection management across various clinical scenarios. The product's consistent formulation and reliable performance make it a trusted choice for medical professionals seeking predictable therapeutic outcomes.

This injection serves multiple healthcare sectors including hospitals, surgical centers, clinics, and emergency care facilities. It plays a crucial role in internal medicine, surgery, pediatrics, and critical care for treating infections such as pneumonia, urinary tract infections, and skin infections. The product is extensively used in orthopedic and obstetric settings for surgical prophylaxis to prevent post-operative complications. Its versatility and proven efficacy make it fundamental to both public and private healthcare systems, supporting robust infection control protocols and enhancing patient outcomes across diverse medical environments and patient populations. The product's broad applicability ensures it meets the needs of various medical specialties while maintaining consistent therapeutic standards.

Healthcare providers benefit from D-xime's consistent quality and reliable performance in treating severe bacterial infections. Produced in compliance with international pharmaceutical standards, it ensures batch-to-batch consistency and regulatory compliance. The product's effectiveness reduces treatment duration and hospital stays, offering significant operational efficiencies while maintaining high therapeutic standards. Its trustworthiness and clinical performance make it a preferred choice for medical distributors and wholesalers, enhancing supply chain efficiency and end-user satisfaction through dependable infection management solutions. The product's reliability translates to predictable outcomes, reducing clinical variability and supporting evidence-based treatment protocols across healthcare institutions.

Key Features:
- Contains Cefuroxime Sodium IP equivalent to 750mg Cefuroxime Anhydrous per vial
- Sterile dry powder formulation for easy reconstitution with appropriate diluents
- Broad-spectrum activity against gram-positive and gram-negative bacteria
- Manufactured under strict quality control and assurance protocols
- Sealed vial packaging ensures sterility and extended shelf life

Benefits:
- Provides reliable treatment for various bacterial infections with consistent dosing
- Ensures rapid therapeutic action supporting timely patient recovery
- Supports infection management across multiple medical departments and specialties
- Reduces treatment duration and associated healthcare operational costs
- Maintains batch-to-batch consistency for predictable clinical outcomes